AMERICAN INTERNATIONAL GROUP, INC. - CUE BIOPHARMA INC ownership

CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 100 filers reported holding CUE BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is 0.49 and the average weighting 0.1%.

Quarter-by-quarter ownership
AMERICAN INTERNATIONAL GROUP, INC. ownership history of CUE BIOPHARMA INC
ValueSharesWeighting
Q3 2023$39,670
-34.7%
17,248
+3.7%
0.00%
Q2 2023$60,718
-19.0%
16,635
+8.9%
0.00%
Q1 2022$75,000
-59.5%
15,272
-6.6%
0.00%
-100.0%
Q4 2021$185,000
-24.5%
16,348
-2.9%
0.00%0.0%
Q3 2021$245,000
+26.3%
16,836
+0.9%
0.00%0.0%
Q2 2021$194,000
-7.6%
16,685
-3.1%
0.00%0.0%
Q1 2021$210,000
-2.3%
17,215
+0.3%
0.00%0.0%
Q4 2020$215,000
-17.0%
17,169
-0.2%
0.00%0.0%
Q3 2020$259,000
-37.7%
17,205
+1.5%
0.00%
-50.0%
Q2 2020$416,000
+147.6%
16,959
+43.5%
0.00%
+100.0%
Q1 2020$168,000
-15.2%
11,817
-5.5%
0.00%0.0%
Q4 2019$198,000
+90.4%
12,500
+1.0%
0.00%
Q3 2019$104,000
+1.0%
12,379
+7.9%
0.00%
Q2 2019$103,000
+14.4%
11,472
-1.0%
0.00%
Q1 2019$90,000
+63.6%
11,589
-0.4%
0.00%
Q4 2018$55,000
-48.1%
11,637
-0.8%
0.00%
Q3 2018$106,000
-22.6%
11,727
+1.8%
0.00%
Q2 2018$137,000
+71.2%
11,516
+102.1%
0.00%
Q1 2018$80,0005,6970.00%
Other shareholders
CUE BIOPHARMA INC shareholders Q1 2022
NameSharesValueWeighting ↓
Corriente Advisors, LLC 820,000$11,636,00012.56%
Prosight Management, LP 552,060$7,834,0003.66%
Nantahala Capital Management 2,503,840$35,529,0001.33%
MANGROVE PARTNERS IM, LLC 601,398$8,534,0001.18%
Voss Capital, LLC 88,670$749,0001.00%
Slate Path Capital LP 870,694$12,355,0000.95%
Avoro Capital Advisors LLC 1,870,000$26,535,0000.90%
Bleichroeder LP 165,000$2,341,0000.61%
683 Capital Management, LLC 640,000$9,082,0000.54%
PA Capital LLC 40,706$578,0000.51%
View complete list of CUE BIOPHARMA INC shareholders